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Background: Observational studies from the USA have suggested that patients with low health literacy (HL) have
higher health care costs and use an inefficient mix of health care services. To date, there were no studies from
Europe that investigated the impact of HL on the use of the health system. The purpose of this study was to
measure functional HL among persons having type 2 diabetes and to investigate the relationship between
functional HL and health care costs and utilization. Methods: The study population were insured persons of the
basic health insurance plan of the largest health insurer in Switzerland. Persons selected for participation had been
reimbursed for diabetes medications in 2010–11, were aged 35–70 years and did not live in a long-term care
institution. The level of functional HL was measured by one screening question. The following dependent
variables were used: total costs, outpatient costs, inpatient costs, days admitted and number of physician visits
attended. All multiple regression analyses were adjusted for age, gender, education, duration of diabetes,
treatment with insulin (yes/no) and other chronic disease (yes/no). Results: High levels of functional HL were
associated with lower total costs (P=0.007), lower outpatient costs (P=0.004) and less physician visits
(P=0.001). In the standard insurance plan with free access to all health professionals subgroup, the effects
found were more pronounced. Conclusions: Persons with low functional HL need extra medical support, and
therefore have higher health care costs.
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Introduction
The ability of citizens to take care of their own health and tonavigate through increasingly complex health care systems has
been recognized as a significant factor in health care costs and
quality.1 Thus, health literacy (HL) has become an important
research topic. The World Health Organization has defined HL as
the ‘‘cognitive and social skills which determine the motivation and
ability of individuals to gain access to, understand and use informa-
tion in ways which promote and maintain good health.’’2 Studies
have shown that limited HL is associated with poorer health
outcomes3,4 and lower use of preventive health services.5–7
For people suffering from diabetes, HL is even more important, as
they have to be able to integrate health-related self-management
activities in their daily life, such as following medication plans,
respecting dietary intake modifications or being able to communi-
cate with health care providers.8 To date, studies of the relationship
between HL and diabetes control have provided mixed results. Some
studies found associations between low HL and worse glycaemic
control,9,10 more hypoglycaemic events11 and higher rates of retin-
opathy.12 Other studies did not confirm a relationship between
glycaemic control and HL.13,14
However, different studies found associations between low
HL and higher total health care spending,15 higher emergency
department use,16 and higher inpatient costs.7,17 Eichler, et al.18
estimated the additional costs on the health system level associated
with low HL in the range of 3 to 5% of the total health care costs per
year. All these studies were based on data from the USA. Considering
the important differences between the European and US living
conditions and the health care systems, these findings cannot be
generalized.
For example, in Switzerland basic health care insurance is
compulsory for all citizens. They can choose between different
insurers, and the insurers are obliged to accept every person in the
basic health care insurance. Independent of the chosen insurer,
the basic health care insurance covers the same medical costs for
diagnostic and therapeutic procedures approved by law. Outpatient
costs include all diagnostic and therapeutic procedures prescribed or
conducted by approved physicians in the ambulatory setting.
Inpatient costs include all diagnostic and therapeutic procedures
undertaken in approved hospitals. Copayment of medical costs by
the insured persons consists of a deductible (annual amount paid by
insured persons towards the costs of medical benefits) and an excess
(percentage of the costs invoiced annually for medical benefits over
and above the amount of the deductible, but no more than the
maximum amount per year specified by law). Insured persons can
choose to pay higher annual deductibles or choose between different
alternative insurance options with a restricted choice of service
providers in return for reduced premiums.
For our study, we selected patients with type 2 diabetes because
diabetes is one of the most common diseases, with 366 million
people affected worldwide in 2011.19 In Switzerland, >300 000
people are suffering from diabetes, with 
15 000 persons newly
diagnosed per year.20 About 2.2% of the country’s total health
care expenditures are spent for the treatment of diabetes and its
complications.21 In particular, persons with a low socioeconomic
status suffer up to four times more frequently from diabetes than
persons with a high socioeconomic status.22
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Even though HL as a concept has been subject to constant changes
and refinements, the development of measurements still lags
behind.23 Although most definitions assume that there is more to
HL than functional literacy, comprehensive tools that capture this
multidimensionality are still lacking.24 The Test of Functional
Health Literacy in Adults (TOFHLA)25 and the Rapid Estimate of
Adult Literacy in Medicine (REALM)26 are two of the most
commonly used measurement tools. Both test measure functional
HL, where the TOFHLA aims at capturing patients’ reading com-
prehension and numeracy skills and REALM captures word recog-
nition and pronunciation skills.
Another way to measure HL is via screening questions. Most of
these questions ask about one’s ability to understand health-related
materials and some have tried to capture the multidimensionality of
the concept. Nevertheless, lack of external validity often poses a
problem, and so far none of these measures have been considered
to be the gold standard.27
The purpose of this study was to measure functional HL among
persons having type 2 diabetes and to examine the relationship
between HL and health care costs and utilization. To the best of
our knowledge, this is the first study conducted in Europe,
combining functional HL measurement of patients suffering from
type 2 diabetes and the cost outcome data.
Methods
Study population
The study population were insured persons of the basic health
insurance plan of the Helsana Group, the largest health insurer in
Switzerland. Persons were eligible for the study if they had been
reimbursed for diabetes medications (Anatomical Therapeutic
Chemical classification system A10A or A10B) in 2010 and 2011,
were not living in a long-term care institution and were aged
between 35 and 70 years.
There are different official languages in different parts of
Switzerland. As HL may interfere with the knowledge of the
language, persons were eligible only if they had chosen the official
language within the region where they were living as the correspond-
ence language with the insurance company.
A randomized sample consisting of 7550 persons in the German-
speaking part, 2926 persons in the French-speaking part and 1111
persons in the Italian-speaking part of Switzerland was contacted by
letter. For enrolment they had to return a consent form by prepaid
envelope to the University of Lugano, indicating whether they were
suffering from type 2 diabetes mellitus.
Interview data
Participants were interviewed by trained students of the University
of Lugano in spring 2012. Telephone interviews were conducted in
three official languages of the respective regions. Collected data
included demographic information, information on health status
and functional HL as measured by one screening item (More
measures of HL have been included in the original questionnaire
but for the purpose of this study it was decided to focus on the
measure for functional HL).
Because TOFHLA or REALM are not suitable for telephone
interviews, we used one of the three screening items developed by
Chew et al.28,29 All three items refer to functional HL, asking patients
about their perceived competence to understand health-related in-
formation material. The studies of Chew et al. showed that the item
‘‘How often do you have problems learning about your medical
condition because of difficulty understanding written information?’’
had an AUROC of 0.76 (95% CI = 0.62–0.90) for identifying persons
with inadequate HL and an AUROC of 0.60 (95% CI = 0.0.51–0.69)
for identifying persons with inadequate or marginal HL. The authors
indicated in their study that the combination of all three items
would not lead to any significant change in detecting HL levels.29
Therefore, we chose only one of the three items because this one was
the most applicable to the Swiss health care context. As the transla-
tion of the original question could be misinterpreted, we used a
slightly adapted version: ‘‘When you get written information on a
medical treatment or your medical condition, how often do you
have problems understanding what it is telling you?’’
The study protocol was approved by the appropriate regional
ethical committee ‘Comitato etico cantonale, Ticino’.
Insurance data
We retrieved all costs and utilization data for2010 and 2011
from the insurer’s administrative database including all
copayments (deductible and excess). We distinguished three
categories of health insurance plans. The standard insurance plan
included free access to all physicians, in the telephone counselling
plan the insured person had to call a medical call centre before going
to a physician and in the gatekeeper-model the insured person had
to first go to a selected physician.
Statistical analysis
We corrected the non-normal distribution of costs and utilization
data by using log transformation. To identify differences between
participants and non-participants in health care costs and utiliza-
tion, we used Levene’s test for homogeneity of variance and the
independent t-test for equality of means.
Multiple regression analyses were conducted to analyse the rela-
tionship between the level of functional HL and health care costs and
utilization. As dependent variables for health care costs, we used
total costs, outpatient costs and inpatient costs. Based on the data
available, the utilization of the health care system was assessed on the
basis of the number of days admitted in hospital and the number of
physician visits attended. Levels of HL were used as independent
dummy variables comparing the different levels of functional HL
with the group having the highest level of functional HL. All
regression models included the covariates age, gender, duration of
diabetes, treatment with insulin, other chronic condition and
education. To control for influences of the chosen health
insurance plan, we performed a subgroup analyses of persons
choosing the standard insurance plan. All statistical analyses were
performed using SPSS version 19.
Results
Sample characteristics
From the 11 587 persons contacted, we received 2075 response cards,
of which 1097 declined participation and 335 persons did not fulfil
the inclusion criteria because they did not have type 2 diabetes. Of
the 588 eligible persons, 34 later declined participation, 57 were not
reachable by phone, 2 did not finish the interview and in 2 cases the
interviewed persons were not the selected persons. Finally, interview
data were obtained from 493 persons (figure 1).
We found that males, or those aged >65 years, or those living in
the German-speaking region of Switzerland, or those having chosen
a higher cost participation or a gatekeeper-model as insurance plan
were more likely to participate (table 1).
Of the 493 participants, 441 (89%) had been diagnosed with type
2 diabetes >5 years ago, and 164 participants (33%) were treated
with insulin. In addition, 227 participants (46%) had other chronic
disease. Twelve persons reported having suffered from diabetes for 1
year or less, but according to the insurance claims data all partici-
pants received medications against diabetes for at least 2 years.
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Half of the participants declared never having problems in under-
standing written information related to their medical condition. In
contrast, 7.3% of the participants often or always had problems
understanding written information (table 2).
Health care costs and utilization
For health care costs and utilization, the Levene’s test was non-sig-
nificant in all categories, confirming the homogeneity of variances in
participants and non-participants.
In 2011, participants on average caused significantly higher total
costs [GM = geometric mean (GM) =E 5155, SE = 1.05 vs. GM =E
4393, SE = 1.01; t (11 585) = 3.10, P = 0.002], higher outpatient costs
(GM =E 4137, SE = 1.04 vs. GM =E 3669, SE = 1.01; t
(11 585) = 3.06, P = 0.002) and more physician visits (GM = 24,
SE = 1.04 vs. GM = 20, SE = 1.01; t (11 199) = 5.10, P < .001) than
non-participants. These differences were confirmed by the data of
2010.
Multiple regression analyses
Multiple regression analyses were conducted to evaluate the associ-
ation between HL and different health care costs and utilization
variables. The results of the regressions suggested that persons
Table 1 Study population characteristics
2011 Participants Non-participants Total v2 P-value
n % N % N %
Gender
Male 332 67.3 6690 60.3 7022 60.6 9.798 0.002
Female 161 32.7 4404 39.0 4565 39.4
Age
35–44 8 1.6 743 6.7 751 6.5 123.231 <0.001
45–54 42 8.5 2258 20.4 2300 19.8
55–64 189 38.3 4743 42.8 4932 42.6
65–70 254 51.5 3350 30.2 3604 31.1
Language
German 391 79.3 7159 64.5 7550 65.2 45.42 <0.001
French 74 15.0 2852 25.7 2926 25.3
Italian 28 5.7 1083 9.8 1111 9.6
Annual deductible
 E 250 350 71.0 7613 68.6 7963 68.7 11.158 0.004
= E 417 105 21.3 2917 26.3 3022 26.1
 E 833 38 7.7 564 5.1 602 5.2
Insurance plan
Standard 274 55.6 7738 69.7 8012 69.1 45.756 <0.001
Telephone counselling 58 11.8 992 8.9 1050 9.1
Gatekeeper model 161 32.7 2364 21.3 2525 21.8
Total 493 100 11 094 100.0 11 587 100
Figure 1 Enrolment process
Table 2 Results of HL screening question
n %
Always 12 2.4
Often 24 4.9
Sometimes 78 15.8
Occasionally 129 26.2
Never 250 50.7
Total 493 100
‘‘When you get written information on a medical treatment or your
medical condition, how often do you have problems understanding
what it is telling you?’’.
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with lower levels of HL caused higher total costs, higher outpatient
costs and had more physician visits (table 3). In the subgroup
analysis of patients who chose the standard insurance plan with
free access to all health professionals, the effects found were more
pronounced (table 4).
Discussion
The study demonstrated that patients with type 2 diabetes with
low functional HL had higher total and outpatient costs. This is
also reflected by the fact that patients with lower HL levels visited
their physicians more frequently than patients with higher levels
of HL, as visiting the physician is reflected in both total and
outpatient costs. Functional HL was operationalized by self-
reported competence to understand written information about
their medical condition.
Some further observations substantiate this finding. Inpatient
costs and the number of days admitted to a hospital also tended
to be higher in low-HL patients, but the difference did not reach a
significant level. Nevertheless, the fact that with each decreasing level
of HL, the association became stronger (increasing regression betas),
further supports the general finding. Improving the evidence
beyond what other studies show, we were able to demonstrate
that the negative relationship between levels of functional HL and
health care costs and health system utilization was stable over the
2 years.
Our findings of a relationship between HL and outpatient costs
and the number of physician visits are in contrast to studies
conducted in the USA, where office visit rates were shown to be
similar across the range of HL scores.15 Further, studies from the
USA showed that lower HL was associated with higher emergency
department and inpatient admission costs,7,15 therby suggesting that
low-HL patients there may use an inefficient mix of health services.
Our results do not suggest similar findings for Switzerland. One
explanation could be the general low number of hospital days in
our sample. Another explanation could be that, in contrast to the
USA, the fast and easy access to physicians in private practices in
Switzerland diminishes the number of hospital admissions and
inpatient costs. This would also explain the greater effect we
found on the physician visits and the outpatient costs. That
people with low HL visit their physician more often can also be
traced back to their worse glycaemic control and/or more
comorbidities and the higher need for medical support caused by
this.
In the subgroup of persons having chosen the standard insurance
plan without telephone counselling or a gatekeeper, the effects were
even more pronounced. This might be due to the fact that persons
with low HL would need these services more, and not having them,
their insecurity in the choice of the appropriate health care provider
results in navigating through turning to the health care system more
frequently.
Our sample showed a low variance of HL levels, which made it
more difficult to discern significant differences. Most studies
identified at least 20% of patients with low HL.30 In our sample,
only 7.3% persons were considered to have inadequate HL. But
according to the Adult Literacy and Life Skills Survey31, at least
40% of the Swiss population have low levels of general problem-
solving, literacy and numeracy skills. As HL is correlated
with education, we assume that persons with low HL were
underrepresented in our sample due to participation bias. Despite
this constraint, the association between low HL and health care costs
and utilization remained significant. The likely underrepresentation
of persons with low HL makes us conclude that our study under-
estimates the true effect of low HL on health care costs and health
care system utilization in Switzerland.
There are several limitations to this study. First, as most of the
participants showed a high level of HL, it is possible that the chosen
item for its measurement was not sufficiently accurate. However,
more established instruments, such as the S-TOFHLA or the
REALM, could not be used for telephone interviews. The next best
choice was a validated item from Chew et al.28,29
Second, although the presence of another chronic disease was
integrated as a covariate in all regression models, we had no
medical data to confirm the self-reported comorbidities. Low HL
could result in underreporting comorbidities, and therefore lead to
overestimation of the effect of low HL on health care costs and use.
On the other hand, more comorbidities could mediate the relation-
ship between low HL and higher health care costs and utilization.30
In this case, controlling for comorbidities could have led to an
underestimation.
Third, even if our study population was representative for patients
with type 2 diabetes in Switzerland, participants and non-partici-
pants were significantly different with regard to age, gender, chosen
insurance plan, total costs, outpatient costs and the number of
physician visits. Therefore, the findings of our study cannot be
considered to be truly representative of patients with type 2
diabetes in Switzerland. Furthermore, due to the low number of
participants from the French- and Italian-speaking regions of
Switzerland, our results reflect mostly the situation in the
German-speaking region of Switzerland. Therefore, our findings
cannot be applied to the two smaller language regions with the
same reliability as to the German-speaking region. However, our
study suggests that even in a country with compulsory health
insurance coverage and a renowned health care system, HL
influences the use of the health care system and the health care
costs. Finally, the observational design does not allow defining if
any association found was causal.
Besides the limitations of this study, several questions remain
unanswered. We used the understanding of written information as
a proxy for low functional HL. But the concept of HL contains far
more than reading and numeracy skills.32,33 Further studies are
needed to better understand the broader concept of HL and
to improve HL measurements. As this is the first study conducted
in Europe to evaluate the relationship between functional HL
and health care costs and utilization, more studies are needed
to investigate the impact of low HL on an individual and societal
level.
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Key points
 Observational studies from the USA have suggested that
patients with low HL have higher health care costs and use
an inefficient mix of health care services.
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 Our study suggests that even in a European country with
compulsory health insurance, HL influences the use of the
health care system and the health care costs.
 Persons with low HL need more medical support, and
therefore have higher health care costs.
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